knowledge -WSS

knowledge

author：fashion 2025-09-30 20:18:38 - browse：96747

Humana sign -- health business coverage from STAT — Humana’s Medicare Advantage business is faring even worse than the company let on last week. Ed Reinke/AP

Humana’s Medicare Advantage business is faring even worse than the company let on last week, with “unprecedented” numbers of older adults getting medical care and busting through its tactics for holding up payment.

The country’s second largest private Medicare insurer disclosed Thursday it’s projecting roughly half the profit in 2024 that investors had expected. The news comes a week after Humana already lowered its projected 2023 profit, which still came in at north of $3 billion before taxes.

The stock market’s punishment was swift and decisive, sinking Humana’s share price by roughly 12% at midday. Outgoing CEO Bruce Broussard worked to calm nerves on the company’s investor call, reiterating his confidence in MA. Humana went all-in on the program when it announced last year it would wind down its employer business, but that comes as regulators are beefing up scrutiny of MA plans.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： Did you have Obamacare on your GOP debate bingo card?

WSS

Three issues to watch in global health in 2024

Generative AI mines health records to identify patients’ social needs

The SUPPORT Act is critical to fighting the opioid crisis

Fauci’s Covid grilling leads GOP to weigh foreign research rules

FDA seeks to regulate lab

The nurse manager staffing crisis is hurting patients

entertainment

knowledge

leisure time

Tori Bowie and the unacceptable rates of Black maternal death

Paxlovid should be available without a positive Covid test

Hepatitis C has a cure — but many Americans still lack access to it

Ionis has late

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Why liver experts renamed NASH to MASH, and NAFLD to MASLD

Affirmative action in medical school literally saved lives

Doudna institute plans to 'cure hundreds of diseases' with CRISPR

As demand for Covid shots wanes, Moderna seeks its next success

New Medicare drug pricing powers could soon be upended in court

Wikipedia

The nurse manager staffing crisis is hurting patients

Ionis has late

Paxlovid should be available without a positive Covid test

Shingles, which affected Dianne Feinstein, is on the rise

Would Medicare drug price negotiations stall in a shutdown?

Health and fitness trackers are measuring the wrong things

hotspot

focus

leisure time

entertainment